Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome

Area of Science:

• Genetics
• Neurodevelopmental Disorders
• Molecular Biology

Background:

• Rett syndrome is a severe X-linked dominant neurodevelopmental disorder.
• The methyl-CpG-binding protein 2 (MECP2) gene is frequently mutated in Rett syndrome patients.

Purpose of the Study:

• To investigate the relationship between specific MECP2 gene mutations and the clinical presentation of Rett syndrome.
• To correlate MECP2 mutation types with disease severity and specific clinical features.

Main Methods:

• Cross-sectional study of 245 individuals with Rett syndrome.
• Analysis of MECP2 mutation status and structured clinical evaluations.
• Comparison of clinical features grouped by MECP2 mutation type.

Main Results:

• MECP2 mutations R133C and R294X are associated with milder disease compared to R168X or large deletions.
• Specific mutations correlate with differences in ambulation, hand use, and language abilities.
• Carboxy-terminal truncating mutations are linked to better outcomes in ambulation and language.

Conclusions:

• MECP2 mutation type significantly influences Rett syndrome severity.
• Genotype-phenotype correlations are crucial for predicting disease trajectory.
• Findings support the development of targeted therapies and informed clinical trial design.